The African Journal of Clinical and Outcomes Research was established to answer in a publication vehicle need for original research articles, clinical reviews and opinion papers on all aspects of clinical research, clinical development, regulatory affairs and ethics, eClinical, outcomes research. The target audience include, but are not limited to, multinational companies, clinical research organisations and site management organisations. The journal also provides a platform for the advertising of positions in the field and enrolment opportunities.

CIPLA LAUNCHES NEW TRIPLE-COMBINATION ANTIRETROVIRAL DRUG, REYDIN

Ahead of World Aids Day and as part of its continued commitment to ensuring access to quality, affordable antiretrovirals (ARV), Cipla is launching its new triple-combination ARV treatment for HIV in South Africa.

Empagliflozin proven to improve clinical outcomes in real world practice across a broad spectrum of cardiovascular risk

The most recent 2018 treatment recommendations from the American Diabetes Association are that, after considering drug specific and patient factors, treatment for people with atherosclerotic cardiovascular disease (ASCVD) should begin with lifestyle management and metformin and subsequently incorporate an agent proven to reduce major adverse cardiovascular events and/or cardiovascular mortality.

Skin protection range, Dexeryl, receives Allergy Foundation’s seal of approval

Partnership brings established international brand to South African consumers with complementary barrier and cleansing presentations for dry skins.

EXPERTS CALL FOR NATIONWIDE ADOPTION OF BUGWISE APP AMONG GPs TO KEEP ANTIBIOTIC RESISTANCE IN CHECK

Amid increased reporting of antibiotic resistance (ABR) worldwide, local health experts have called on South African doctors to more fully participate in and support efforts aimed at curbing the growing threat of antibiotic resistant superbugs in our country.

New Novartis South Africa CEO to continue building on partnerships

Novartis South Africa aims to continue building on local partnerships and health development initiatives, following the appointment of Dr. Mahomed (Mo) Kadwa as the company’s new Chief Executive Officer: Novartis South Africa and Head: Southern African Countries.

Wildcard SSL